Enfanos Announces Agreement with Waters to Advance Mass Spectrometry Solutions for Newborn Screening Research and Applications Agreement underscores Enfanos’ dedication to advancing scientific discovery and supporting the newborn screening community. Enfanos announced a co-marketing agreement with Waters Corporation , a global leader in mass spectrometry technologies. This agreement enables Enfanos to seamlessly connect innovative enzyme activity and biomarker assay products,